Immunologic response to fungus is not universally associated with rhinosinusitis
This article was presented at the 2008 Annual Meeting of the American Academy of Otolaryngic Allergy, Chicago IL, September 19, 2008.
Received 31 August 2009; accepted 21 September 2009.
Abstract
Objective
Immunologic response to fungal antigens has been cited as an etiologic factor in chronic rhinosinusitis (CRS). Previous work demonstrated a significant cytokine response in CRS patients that did not correlate with an immunoglobulin E (IgE) response. This study was performed in an effort to replicate these findings in a more geographically diverse population.
Design
Prospective in vitro study.
Setting
Two academic tertiary rhinologic practices in Texas and Utah.
Methods
Serum and peripheral blood monocytes (PBMC) were obtained from 10 CRS patients and seven controls. Total IgE and fungal-specific IgE levels were determined. Cytokine levels were measured after PBMC exposure to Alternaria, Aspergillus, Cladosporium, and Penicillium extracts. Correlations between cytokine responses and presence of CRS as well as IgE and IgG were determined.
Results
Interleukin-5 (IL-5) was produced after Alternaria extract exposure in both CRS patients and controls, but the production was heterogenous and did not correlate with the presence of CRS. IL-5 levels after Alternaria extract exposure correlated strongly with levels of Alternaria-specific IgE in both CRS patients and controls. IL-5 production did not correlate with IgG levels. IL-4, IL-13, and interferon-gamma production did not differ between CRS patients and controls.
Conclusions
In contrast to previously reported data, IL-5 responses to Alternaria extract were not predictive of CRS presence. Our results in patients from Utah and Texas significantly differ from previously published findings in predominantly Midwestern patients. The immunologic response to fungal extracts appears to be heterogenous and may differ based on geography, allergy status, and/or other as-yet unknown factors.
aDivision of Otolaryngology–Head and Neck Surgery, University of Utah, Salt Lake City, Utah
bDepartment of Dermatology, University of Utah, Salt Lake City, Utah
cOtolaryngology–Head and Neck Surgery Section, George E. Wahlen Veteran Affairs Medical Center, Salt Lake City, Utah
dDepartment of Otolaryngology–Head and Neck Surgery, University of Texas-Southwestern, Dallas, Texas
Corresponding author: Richard R. Orlandi, MD, 50 North Medical Drive, 3C120, Salt Lake City, UT 84132
Sponsorships or competing interests that may be relevant to content are disclosed at the end of this article.
ABSTRACT